- S. Beinhardt, R. Al-Zoairy, K. Kozbial, AF. Stättermayer, A. Maieron, R. Stauber, M. Strasser, H. Zoller, I. Graziadei, S. Rasoul-Rockenschaub, M. Trauner, P. Ferenci, H. Hofer
Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation.
Liver Int. 2018 Jul;38(7):1188-1197
- T. Bucsics, M. Schoder, M. Diermayr, M. Feldner-Busztin, N. Goeschl, D. Bauer, P. Schwabl, M. Mandorfer, B. Angermayr, M. Cejna, A. Ferlitsch, W. Sieghart, M. Trauner, M. Peck-Radosavljevic, J. Karner, F. Karnel, T. Reiberger
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience
PLoS One. 2018 Jan 9;13(1):e0189414
- D. Chromy, P. Schwabl, T. Bucsics, B. Scheiner, R. Strassl, F. Mayer, MC.
Aichelburg, K. Grabmeier-Pfistershammer, M. Trauner, M. Peck-Radosavljevic, T. Reiberger, M. Mandorfer
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.
Wien Klin Wochenschr. 2018 Feb;130(3-4):105-114
- Y. Kamogawa-Schifter, Y. Yamaoka, T. Uchida, A. Beer, B. Tribl, M. Schöniger-
Hekele, M. Trauner, W. Dolak - Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and
duodenal ulcer at an Austrian tertiary referral center over 25 years.
PLoS One. 2018 May 29;13(5):e0197695
- A. Drolz, T. Horvatits, K. Roedl, K. Rutter, R. Brunner, C. Zauner, P. Schellongowski, G. Heinz, GC. Funk, M. Trauner, B. Schneeweiss, V. Fuhrmann
Acid-base status and its clinical implications in critically ill patients with cirrhosis,
acute-on-chronic liver failure and without liver disease
Ann Intensive Care. 2018 Apr 19;8(1):48
- A. Drolz, T. Horvatits, K. Rutter, F. Landahl, K. Roedl, P. Meersseman, A. Wilmer, J. Kluwe, AW. Lohse, S. Kluge, M. Trauner, V. Fuhrmann
Lactate improves prediction of short-term mortality in critically ill cirrhosis patients: a multinational study.
Hepatology. 2018 Aug 2
- A. Eser, C. Primas, S. Reinisch, H. Vogelsang, G. Novacek, DR. Mould, W. Reinisch
Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System
J Clin Pharmacol. 2018 Jan 30. - JJ. Feld, DE. Bernstein, Z. Younes, HV. Vlierberghe, L.Larsen, F. Tatsch, P. Ferenci
Ribavirin dose management in HCV patients receiving ombitasvir / paritaprevir/ritonavir and dasabuvir with ribavirin
Liver Int. 2018 Jan 27.
- Weiss KH, Członkowska A, Hedera P, Ferenci P.
WTX101 - an investigational drug for the treatment of Wilson disease.
Expert Opin Investig Drugs. 2018 Jun 8:1-7
- R. Schwarzer, D. Kivaranovic, M. Mandorfer, R. Paternostro, D. Wolrab, B. Heinisch, T. Reiberger, M. Ferlitsch, C. Gerner, M. Trauner, M. Peck-Radosavljevic, A. Ferlitsch
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal
hypertension
Aliment Pharmacol Ther. 2018 Jan;47(1):86-94
- R. Schwarzer, D. Kivaranovic, R. Paternostro, M. Mandorfer, T. Reiberger, M. Trauner, M. Peck-Radosavljevic, A. Ferlitsch
Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study
Aliment Pharmacol Ther. 2018 Apr;47(8):1162-1169
- I. Gessl, E. Waldmann, M. Britto-Arias, D. Penz, E. Pablik, M. Trauner, M. Ferlitsch
Surveillance colonoscopy in Austria: Are we following the guidelines?
Endoscopy. 2018 Feb;50(2):119-127
- A. Frick, V. Khare, G. Paul, M. Lang, F. Ferk, S. Knasmüller, A. Beer, G. Oberhuber, C. Gasche
Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia
Mol Cancer Res. 2018 Apr;16(4):634-642
- CD. Fuchs, G. Paumgartner, V. Mlitz, V. Kunczer, E. Halilbasic, N. Leditznig, A. Wahlström, M. Ståhlman, A. Thüringer, K. Kashofer, T. Stojakovic, HU. Marschall, M. Trauner
Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2-/- mice by modulating composition, signalling and excretion of faecal bile acids
Gut. 2018 Apr 10. pii: gutjnl-2017-314553
- N. Granofszky, M. Lang, V. Khare, G. Schmid, T. Scharl, F. Ferk, K. Jimenez, S. Knasmüller, C. Campregher, C. Gasche
Identification of PMN-released mutagenic factors in a co-culture model for colitisassociated cancer
Carcinogenesis. 2018 Feb 9;39(2):146-157
- J. Gautherot, T. Claudel, F. Cuperus, CD. Fuchs, T. Falguieres, M. Trauner
Thyroid hormone receptor β1 stimulates ABCB4 to increase biliary phosphatidylcholine excretion in mice.
J Lipid Res. 2018 Jun 12
- V. Hammer, K. Hammer, N. Memaran, WD. Huber, K. Hammer, J. Hammer
Correction to: Relationship Between Abdominal Symptoms and Fructose Ingestion in Children with Chronic Abdominal Pain
Dig Dis Sci. 2018 Apr 2. doi: 10.1007/s10620-018-5046-z
- J. Hammer
Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test
Am J Gastroenterol. 2018 Apr;113(4):584-592
- P. Jha P, MT. McDevitt, E. Halilbasic, EG. Williams, PM. Quiros, K. Gariani, MB.
Sleiman, R. Gupta, A. Ulbrich, A. Jochem, JJ. Coon, M. Trauner, DJ. Pagliarini, J. Auwerx
Genetic Regulation of Plasma Lipid Species and Their Association with Metabolic Phenotypes.
Cell Syst. 2018 Jun 27;6(6):709-721
- UJ. Lemberger, CD. Fuchs, C. Schöfer, A. Bileck, C. Gerner, T. Stojakovic, MM. Taketo, M. Trauner, G. Egger, C. Österreicher
Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice
Oncotarget. 2018 Jan 30;9(13):11243-11257
- K. Kozbial, S. Moser, R. Al-Zoairy, R. Schwarzer, C. Datz, R. Stauber, H. Laferl, M. Strasser, S. Beinhardt, AF. Stättermayer, M. Gschwantler, H. Zoller, A. Maieron, I. Graziadei, M. Trauner, P. Steindl-Munda, H. Hofer, P. Ferenci
Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
Liver Int. 2018 Jun;38(6):1028-1035
- P. Königshofer, K. Brusilovskaya, P. Schwabl, T. Reiberger
Animal models of portal hypertension.
Biochim Biophys Acta. 2018 Jul 25
- C. Madl, U. Madl
Gastrointestinal motility in critically ill patients
Med Klin Intensivmed Notfmed. 2018 Jun;113(5):433-442
- M. Mandorfer, T. Reiberger, M. Peck-Radosavljevic
Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response.
Gastroenterology. 2018 Apr;154(5):1550-1551
- M. Mandorfer, P. Schwabl, R. Paternostro, K. Pomej, D. Bauer, J. Thaler, C. Ay, P. Quehenberger, M. Fritzer-Szekeres, M. Peck-Radosavljevic, M. Trauner, T.
Reiberger, A. Ferlitsch; Vienna Hepatic Hemodynamic Lab
Von Willebrand factor indicates bacterial translocation, inflammation, and
procoagulant imbalance and predicts complications independently of portal hypertension severity.
Aliment Pharmacol Ther. 2018 Apr;47(7):980-988
- M. Mandorfer, T. Bucsics, V. Hutya, K. Schmid-Scherzer, B. Schaefer, H. Zoller, A. Ferlitsch, M. Peck-Radosavljevic, M. Trauner, P. Ferenci, M. Kneussl, T. Reiberger
Liver disease in adults with α1-antitrypsin deficiency.
United European Gastroenterol J. 2018 Jun;6(5):710-718
- M. Mandorfer, B. Scheiner, AF. Stättermayer, P. Schwabl, R. Paternostro, D. Bauer, B. Schaefer, H. Zoller, M. Peck-Radosavljevic, M. Trauner, T. Reiberger, P. Ferenci, A. Ferlitsch
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.
Aliment Pharmacol Ther. 2018 Jun 29
- G. Moser, C. Fournier, J. Peter
Intestinal microbiome-gut-brain axis and irritable bowel syndrome
Wien Med Wochenschr. 2018 Mar;168(3-4):62-66
- W. Miehsler, C. Dejaco, HP. Gröchenig, H. Fuchssteiner, C. Högenauer, L. Kazemi Shirazi, H. Maier, A. Mayer, A. Moschen, W. Reinisch, W. Petritsch, R. Platzer, P. Steiner, H. Tilg, H. Vogelsang, H. Wenzl, G. Novacek
Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases
Z Gastroenterol. 2018 Mar;56(3):275-302
- R. Paternostro, BB. Heinisch, T. Reiberger, M. Mandorfer, R. Schwarzer, B. Seeland, M. Trauner, M. Peck-Radosavljevic, A. Ferlitsch
Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension
Liver Int. 2018 Jan 24.
- M. Pinter, WJ. Kwanten, RK. Jain
Renin-angiotensin system inhibitors to mitigate cancer treatment-related adverse events
Clin Cancer Res. 2018 Apr 2
- C. Primas, H. Vogelsang, M. Bergmann
Inflammatory bowel disease: What does the clinician want to know from the radiologist?
Radiologe. 2018 Apr;58(4):320-325
- N. Pfisterer, C. Dexheimer, EM. Fuchs, T. Bucsics, P. Schwabl, M. Mandorfer, I. Gessl, L. Sandrieser, L. Baumann, F. Riedl, B. Scheiner, T. Pachofszky, W. Dolak, C. Schrutka-Kölbl, A. Ferlitsch, M. Schöniger-Hekele, M. Peck-Radosavljevic, M. Trauner, C. Madl, T. Reiberger
Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.
Aliment Pharmacol Ther. 2018 Apr;47(7):966-979
- GH. Lo, T. Reiberger
Peptic ulcer bleeding in patients with cirrhosis: Is it as bad as variceal bleeding?
Hepatology. 2018 Apr;67(4):1219-1220
- W. Reinisch, K. Hung, M. Hassan-Zahraee, F. Cataldi
Targeting endothelial ligands: (ICAM-1/Alicaforsen, MAdCAM-1)
J Crohns Colitis. 2018 May 11.
- W. Reinisch, JF. Colombel, PR. Gibson, P. Rutgeerts, WJ. Sandborn, D. Tarabar,S. Huyck, A. Khalifa, C. Marano, G. Philip, R. Yao, H. Zhang, F. Cornillie
Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab.
Inflamm Bowel Dis 2018
- W. Reinisch, PR. Gibson, WJ. Sandborn, BG. Feagan, R. Strauss, J. Johanns, L. Padgett, OJ. Adedokun, JF. Colombel, J. Collins, P. Rutgeerts, D. Tarabar, C.
- Marano
Long-term Benefit of Golimumab for Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension.
J Crohns Colitis. 2018 Jun 18
- N. Rohr-Udilova, E. Bauer, G. Timelthaler, R. Eferl, K. Stolze, M. Pinter, M. Seif, H. Hayden, T. Reiberger, R. Schulte-Hermann, M. Peck-Radosavljevic, D. Stoiber, M. Trauner
Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma
Oncotarget. 2018 Jan 22;9(11):10054-10068
- N. Rohr-Udilova, F. Klinglmüller, R. Schulte-Hermann, J. Stift, M. Herac, M. Salzmann, F. Finotello, G. Timelthaler, G. Oberhuber, M. Pinter, T. Reiberger, E. Jensen-Jarolim, R. Eferl, M. Trauner
Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
Sci Rep. 2018 Apr 18;8(1):6220. doi: 10.1038/s41598-018-24437-5
- B. Scheiner, PR. Stammet, S. Pokorny, T. Bucsics, P. Schwabl, A. Brichta, J. Thaler, K. Lampichler, A. Ba-Ssalamah, C. Ay, A. Ferlitsch, M. Trauner, M. Mandorfer, T. Reiberger
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
Wien Klin Wochenschr. 2018 Jun 18
- M. Schneeweiss, B. Peter, S. Bibi, G. Eisenwort, D. Smiljkovic, K. Blatt, M. Jawhar, D. Berger, G. Stefanzl, S. Herndlhofer, G. Greiner, G. Hoermann, E. Hadzijusufovic, KV. Gleixner, P. Bettelheim, K. Geissler, WR. Sperr, A. Reiter, M. Arock, P. Valent
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
Haematologica. 2018 May;103(5):799-809
- M. Tardelli, T. Claudel, FV. Bruschi, M. Trauner
Nuclear Receptor Regulation of Aquaglyceroporins in Metabolic Organs.
Int J Mol Sci. 2018 Jun 15;19(6).
- JP. Arab, M. Arrese, M. Trauner
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Annu Rev Pathol. 2018 Jan 24;13:321-350
- M. Wewalka, A. Drolz, B. Seeland, M. Schneeweiss, M. Schmid, B. Schneeweiss, C. Zauner
Different enteral nutrition formulas have no effect on glucose homeostasis but on dietinduced thermogenesis in critically ill medical patients: a randomized controlled trial
Eur J Clin Nutr. 2018 Apr;72(4):496-503
